agilon health, inc. (NYSE:AGL) Given Consensus Rating of "Reduce" by Brokerages

agilon health, inc. (NYSE:AGL - Get Free Report) has received an average recommendation of "Reduce" from the twenty research firms that are currently covering the company, MarketBeat reports. Three investment analysts have rated the stock with a sell recommendation, fifteen have given a hold recommendation and two have issued a buy recommendation on the company. The average 1-year price target among analysts that have updated their coverage on the stock in the last year is $6.05.

A number of equities research analysts recently issued reports on the company. Evercore ISI reduced their target price on agilon health from $7.00 to $4.00 and set an "in-line" rating on the stock in a research note on Tuesday, October 8th. Deutsche Bank Aktiengesellschaft dropped their price objective on agilon health from $5.00 to $4.00 and set a "hold" rating for the company in a research report on Friday, August 9th. Benchmark restated a "buy" rating and issued a $9.00 target price on shares of agilon health in a report on Thursday, August 8th. Royal Bank of Canada reissued an "outperform" rating and issued a $3.00 price objective on shares of agilon health in a research report on Tuesday, November 19th. Finally, JMP Securities lowered shares of agilon health from an "outperform" rating to a "market perform" rating in a research report on Monday, November 11th.

Insider Buying and Selling

In other news, CEO Steven Sell acquired 20,000 shares of the stock in a transaction on Thursday, September 12th. The stock was bought at an average price of $3.36 per share, with a total value of $67,200.00. Following the completion of the transaction, the chief executive officer now directly owns 67,590 shares of the company's stock, valued at $227,102.40. The trade was a 42.03 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 3.20% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the company. J.Safra Asset Management Corp boosted its position in agilon health by 626.1% in the 2nd quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company's stock valued at $27,000 after buying an additional 3,625 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. purchased a new position in agilon health in the third quarter valued at about $28,000. City State Bank acquired a new stake in agilon health during the 3rd quarter valued at approximately $52,000. CWM LLC increased its holdings in agilon health by 406.5% during the 2nd quarter. CWM LLC now owns 9,081 shares of the company's stock worth $59,000 after purchasing an additional 7,288 shares during the last quarter. Finally, Nisa Investment Advisors LLC acquired a new position in shares of agilon health in the 2nd quarter valued at approximately $60,000.

agilon health Price Performance

AGL stock traded down $0.02 during midday trading on Friday, hitting $2.09. 2,838,072 shares of the stock were exchanged, compared to its average volume of 4,926,008. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29. The stock has a market cap of $861.12 million, a price-to-earnings ratio of -2.22 and a beta of 0.60. agilon health has a fifty-two week low of $1.50 and a fifty-two week high of $13.76. The stock's 50-day moving average price is $2.73 and its 200-day moving average price is $4.63.

agilon health (NYSE:AGL - Get Free Report) last issued its quarterly earnings data on Thursday, November 7th. The company reported ($0.29) EPS for the quarter, missing analysts' consensus estimates of ($0.10) by ($0.19). The business had revenue of $1.45 billion during the quarter, compared to analyst estimates of $1.47 billion. agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. During the same period in the previous year, the company posted ($0.06) earnings per share. Research analysts predict that agilon health will post -0.47 earnings per share for the current year.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.